CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies
Dimitrios Patoulias, Michael Doumas
Endocrinol Metab. 2021;36(4):904-908.   Published online July 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.1048

Excel Download

Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies
Dimitrios Patoulias, Michael Doumas
Endocrinology and Metabolism. 2021;36(4):904-908   Crossref logo
Link1 Link2 Link3
Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis
K. Gooßen, S. Gräber
Diabetes, Obesity and Metabolism. 2012;14(12):1061-1072   Crossref logo
Link1 Link2
Meta-analysis of dipeptidyl peptidase-4 inhibitors use and cardiovascular risk in patients with type 2 diabetes mellitus
Masayuki Kaneko, Mamoru Narukawa
Diabetes Research and Clinical Practice. 2016;116:171-182   Crossref logo
Link1 Link2
The Effect of Dipeptidyl Peptidase-4 Inhibitors on Carotid Intima-media Thickness in Patients With Type 2 Diabetes Mellitus: a Meta-analysis
Hua-song Xia, Yue Liu, Yang Fu, Meng Li, Yan-qing Wu
. 2020;   Crossref logo
Link1 Link2
Efficacy of Dipeptidyl Peptidase-4 Inhibitors on Leptin in type 2 Diabetes Mellitus: A Meta-Analysis
xin wei, yu bai, zhuo wang, xiaohong zheng, zening jin, xin liu
. 2021;   Crossref logo
Link1 Link2
Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis
D. Wu, L. Li, C. Liu
Diabetes, Obesity and Metabolism. 2013;16(1):30-37   Crossref logo
Link1 Link2
Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
Gagik Radikovich Galstyan, Svetlana Viktorovna Sergeeva
Diabetes mellitus. 2015;18(4):87-91   Crossref logo
Link1 Link2
The role of dipeptidyl peptidase 4 inhibitors in fat metabolism in patients with type 2 diabetes and obesity
Aleksander Sergeevich Ametov, Dinara Gadgimagomedovna Gusenbekova
Diabetes mellitus. 2015;18(3):85-92   Crossref logo
Link1 Link2
Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis
Dan Liu, Biao Jin, Wei Chen, Peng Yun
BMC Pharmacology and Toxicology. 2019;20(1):   Crossref logo
Link1 Link2 Link3
Effect of Dipeptidyl Peptidase-4 Inhibitors on Hemoglobin a1c In Patients with Type 2 Diabetes Mellitus and Renal Impairment: a Systematic Review and Meta-analysis
D. Singh-Franco, C. Harrington, E. Tellez-Corrales
Value in Health. 2015;18(3):A55   Crossref logo
Link1 Link2